Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome
Open Access
- 17 January 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (1) , e30414
Abstract
Visceral obesity is associated with the rising incidence of type 2 diabetes and metabolic syndrome. Low-grade chronic inflammation and oxidative stress synergize in obesity and obesity-induced disorders. We searched a cluster of molecules that support interactions between these stress conditions in monocytes. RNA expressions in blood monocytes of two independent cohorts comprising 21 and 102 obese persons and 46 age-matched controls were determined by microarray and independently validated by quantitative RT-PCR analysis. The effect of three-month weight loss after bariatric surgery was determined. The effect of RNA silencing on inflammation and oxidative stress was studied in human monocytic THP-1 cells. Interleukin-1 receptor-associated kinase-3 (IRAK3), key inhibitor of IRAK/NFκB-mediated chronic inflammation, is downregulated in monocytes of obese persons. Low IRAK3 was associated with high superoxide dismutase-2 (SOD2), a marker of mitochondrial oxidative stress. A comparable expression profile was also detected in visceral adipose tissue of the same obese subjects. Low IRAK3 and high SOD2 was associated with a high prevalence of metabolic syndrome (odds ratio: 9.3; sensitivity: 91%; specificity: 77%). By comparison, the odds ratio of high-sensitivity C-reactive protein, a widely used marker of systemic inflammation, was 4.3 (sensitivity: 69%; specificity: 66%). Weight loss was associated with an increase in IRAK3 and a decrease in SOD2, in association with a lowering of systemic inflammation and a decreasing number of metabolic syndrome components. We identified the increase in reactive oxygen species in combination with obesity-associated low adiponectin and high glucose and interleukin-6 as cause of the decrease in IRAK3 in THP-1 cells in vitro. IRAK3 is a key inhibitor of inflammation in association with obesity and metabolic syndrome. Our data warrant further evaluation of IRAK3 as a diagnostic and prognostic marker, and as a target for intervention.Keywords
This publication has 45 references indexed in Scilit:
- TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growthOncogene, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- Changes in C-reactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndromeMetabolism, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- High Glucose Induces Toll-Like Receptor Expression in Human MonocytesDiabetes, 2008
- Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic SyndromeJAMA, 2008
- Inflammation and metabolic disordersNature, 2006
- Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCRBiological Procedures Online, 2006
- Sepsis-induced suppression of lung innate immunity is mediated by IRAK-MJournal of Clinical Investigation, 2006
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002